E-ISSN 2231-3206 | ISSN 2320-4672
 

Case Report

Online Publishing Date:
13 / 08 / 2020

 


Blue nails in chronic myeloid leukemia – Is it usual?

Jaydeep Raj Damor, Jaya Chakravarty, Madhukar Rai, Manaswi Chaubey, Priyanka Kumari, Akash Rai, Ashish Anand Pushpakar, Praveen Kumar Chaturvedi.


Abstract
Nail toxicity is an uncommon cutaneous adverse effect of imatinib mesylate. Here, we have described a 45-year-old female, a diagnosed case of Philadelphia positive chronic myeloid leukemia, who was on imatinib mesylate for the past 3 months and developed bluish discoloration of the nails. This discoloration was related to the drug imatinib mesylate because the patient was only on imatinib and thyroxine medication. No any other skin-related diseases was present, which can lead to her nail changes.

Key words: Bluish Nail; Imatinib; Chronic Myeloid Leukemia


 
ARTICLE TOOLS
Abstract
PDF Fulltext
How to cite this articleHow to cite this article
Citation Tools
Related Records
 Articles by Jaydeep Raj Damor
Articles by Jaya Chakravarty
Articles by Madhukar Rai
Articles by Manaswi Chaubey
Articles by Priyanka Kumari
Articles by Akash Rai
Articles by Ashish Anand Pushpakar
Articles by Praveen Kumar Chaturvedi
on Google
on Google Scholar


How to Cite this Article
Pubmed Style

Damor JR, Chakravarty J, Rai M, Chaubey M, Kumari P, Rai A, Pushpakar AA, Chaturvedi PK. Blue nails in chronic myeloid leukemia – Is it usual?. Natl J Physiol Pharm Pharmacol. 2020; 10(12): 1160-1162. doi:10.5455/njppp.2020.10.06167202001082020


Web Style

Damor JR, Chakravarty J, Rai M, Chaubey M, Kumari P, Rai A, Pushpakar AA, Chaturvedi PK. Blue nails in chronic myeloid leukemia – Is it usual?. https://www.njppp.com/?mno=119052 [Access: March 14, 2024]. doi:10.5455/njppp.2020.10.06167202001082020


AMA (American Medical Association) Style

Damor JR, Chakravarty J, Rai M, Chaubey M, Kumari P, Rai A, Pushpakar AA, Chaturvedi PK. Blue nails in chronic myeloid leukemia – Is it usual?. Natl J Physiol Pharm Pharmacol. 2020; 10(12): 1160-1162. doi:10.5455/njppp.2020.10.06167202001082020



Vancouver/ICMJE Style

Damor JR, Chakravarty J, Rai M, Chaubey M, Kumari P, Rai A, Pushpakar AA, Chaturvedi PK. Blue nails in chronic myeloid leukemia – Is it usual?. Natl J Physiol Pharm Pharmacol. (2020), [cited March 14, 2024]; 10(12): 1160-1162. doi:10.5455/njppp.2020.10.06167202001082020



Harvard Style

Damor, J. R., Chakravarty, . J., Rai, . M., Chaubey, . M., Kumari, . P., Rai, . A., Pushpakar, . A. A. & Chaturvedi, . P. K. (2020) Blue nails in chronic myeloid leukemia – Is it usual?. Natl J Physiol Pharm Pharmacol, 10 (12), 1160-1162. doi:10.5455/njppp.2020.10.06167202001082020



Turabian Style

Damor, Jaydeep Raj, Jaya Chakravarty, Madhukar Rai, Manaswi Chaubey, Priyanka Kumari, Akash Rai, Ashish Anand Pushpakar, and Praveen Kumar Chaturvedi. 2020. Blue nails in chronic myeloid leukemia – Is it usual?. National Journal of Physiology, Pharmacy and Pharmacology, 10 (12), 1160-1162. doi:10.5455/njppp.2020.10.06167202001082020



Chicago Style

Damor, Jaydeep Raj, Jaya Chakravarty, Madhukar Rai, Manaswi Chaubey, Priyanka Kumari, Akash Rai, Ashish Anand Pushpakar, and Praveen Kumar Chaturvedi. "Blue nails in chronic myeloid leukemia – Is it usual?." National Journal of Physiology, Pharmacy and Pharmacology 10 (2020), 1160-1162. doi:10.5455/njppp.2020.10.06167202001082020



MLA (The Modern Language Association) Style

Damor, Jaydeep Raj, Jaya Chakravarty, Madhukar Rai, Manaswi Chaubey, Priyanka Kumari, Akash Rai, Ashish Anand Pushpakar, and Praveen Kumar Chaturvedi. "Blue nails in chronic myeloid leukemia – Is it usual?." National Journal of Physiology, Pharmacy and Pharmacology 10.12 (2020), 1160-1162. Print. doi:10.5455/njppp.2020.10.06167202001082020



APA (American Psychological Association) Style

Damor, J. R., Chakravarty, . J., Rai, . M., Chaubey, . M., Kumari, . P., Rai, . A., Pushpakar, . A. A. & Chaturvedi, . P. K. (2020) Blue nails in chronic myeloid leukemia – Is it usual?. National Journal of Physiology, Pharmacy and Pharmacology, 10 (12), 1160-1162. doi:10.5455/njppp.2020.10.06167202001082020